Andrew utilizes his background in organic and medicinal chemistry to assist clients in patent prosecution and strategic development of patent portfolios in the U.S. and abroad. He works with a wide range of early-stage and established biotechnology and medical device companies on the drafting and prosecution of patent applications. He also assists with intellectual property due diligence through the evaluation of client and competitor portfolios.
Andrew’s research focused on the synthesis of biologically relevant small molecules. In his doctoral studies, Andrew developed new synthetic methodologies for the synthesis of complex natural products. As a medicinal chemistry fellow at the Broad Institute of MIT and Harvard University, Andrew focused on the design and synthesis of small molecules to identify chemical probes to study the functions of genes, cells, and biochemical pathways in the areas of oncology, infectious disease, and neuroscience.
Andrew is an inventor on several patents and patent applications, and has co-authored publications in several journals, including Angewandte Chemie, Journal of Organic Chemistry, ACS Medicinal Chemistry Letters, and Bioorganic Medicinal Chemistry Letters.